JUSTINE SOSCIA: Open Payments
NPI 1609014760 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 52 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $601 · 2025 $1,546
Food & beverage: $1,384Education: $162
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $146 |
| Novocure Inc. | 1 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $138 |
| Celgene Corporation | 3 | $120 |
| Daiichi Sankyo Inc. | 4 | $119 |
| Lilly USA, LLC | 2 | $114 |
| ABBVIE INC. | 2 | $100 |
| Gilead Sciences, Inc. | 3 | $74 |
| Kite Pharma, Inc. | 2 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
Products named: Optune Lua (NovoTTF-200T), REBLOZYL, Enhertu, KEYTRUDA, FRUZAQLA, VENCLEXTA, Trodelvy, Yescarta.
Industry payments across FL — which companies pay providers there.
